Mkt Cap A$30m SOI 1.4 Billion (yikes!) Partners - Astrazeneca and Thermo Fisher
LBT Innovations Limited (LBT, formerly LabTech Systems) is a developer of clinical and diagnostic technology, based in Adelaide, South Australia. The Company has product named as Automated Plate Assessment System (APAS) in microbiology automation.
On a FA front they announced an Australian sale today. I think this may be the start of a faster take up of sales now that the device has passed AZ's requirements, and they are doing some internal testing themselves. This either makes a lot of sales within 12 months or gts bought out, and either way, I think interest is gaining.
TA - price has bounced at support/resistance line, and recent spike shows where this could go to in the short term, though I believe longer term it is higher by a fair margin. I have been accumulating this
As an aside @kenjikool, do you follow this one. Prefer this to MEM at present
